# FDA Inspection 1097479 - Syngene International Limited - June 14, 2019

Source: https://www.keypedia.com/records/fda_inspections/syngene-international-limited/93083d86-9120-4eab-8ceb-a0ea77d003f5
Source feed: FDA_Inspections

> FDA Inspection 1097479 for Syngene International Limited on June 14, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097479
- Company Name: Syngene International Limited
- Inspection Date: 2019-06-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1190200 - 2022-10-28](https://www.keypedia.com/records/fda_inspections/syngene-international-limited/83db090b-eb2e-405f-b6ce-f5ba68d5a6e7)
- [FDA Inspection 1123153 - 2020-02-28](https://www.keypedia.com/records/fda_inspections/syngene-international-limited/0f674550-14e4-4996-a2fe-346cc8049e43)
- [FDA Inspection 1045859 - 2018-01-26](https://www.keypedia.com/records/fda_inspections/syngene-international-limited/e7401b11-a42b-4f4e-862e-7c76c9db7218)

Company: https://www.keypedia.com/companies/syngene-international-limited/143a11af-8f86-4e8a-9a11-f629565a27da

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c